Identification of a conserved subset of cold tumors responsive to immune checkpoint blockade
J. Moore, J. Gkantalis, I. Guix, W. Chou, K. Yuen, A. Lazar, M. H. Spitzer, A. Combes, M. H. Barcellos-Hoff
This study identifies a biomarker, {beta}Alt, that predicts immune checkpoint blockade response in cold tumors by integrating TGF{beta} signaling, DNA repair, and immune context signatures.
bioRxiv · Mar 6, 2024 · PreprintCancer Biology